VC
LRMR icon

Vivo Capital’s Larimar Therapeutics LRMR Stock Holding History

Vivo Capital’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-399,830
Closed -$4.31M – 56
2021
Q4 		$4.31M Hold
399,830
– – 0.26% 48
2021
Q3 		$4.61M Sell
399,830
-399,832
-50% -$4.8M 0.21% 52
2021
Q2 		$7.85M Hold
799,662
– – 0.34% 47
2021
Q1 		$11.7M Hold
799,662
– – 0.41% 39
2020
Q4 		$17.1M Hold
799,662
– – 0.76% 30
2020
Q3 		$12.1M Hold
799,662
– – 0.7% 38
2020
Q2 		$10.3M Buy
+799,662
New +$9.31M 0.74% 31

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return